EUVIMEDEUVIMED entdecken
Open Access

Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention

Juan C Becerra, Lauren Hitchcock, Khoa Vu, Johannes S Gach

Microbial Cell · 03.07.2024 · 11 · 207-220

DOI: 10.15698/mic2024.07.826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Cell, online erschienen am 03.07.2024. Verfasst von Juan C Becerra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, University of California CA, Irvine, Irvine, 92697 USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Broadly neutralizing antibodies (bnAbs) targeting the human immunodeficiency virus-1 (HIV-1) have played a crucial role in elucidating and characterizing neutralization-sensitive sites on the HIV-1 envelope spike and in informing vaccine development. Continual advancements in identifying more potent bnAbs, along with their capacity to trigger antibody-mediated effector functions, coupled with modifications to extend their half-life, position them as promising candidates for both HIV-1 treatment and prevention. While current pharmacological interventions have made significant progress in managing HIV-1 infection and enhancing quality of life, no definitive cure or vaccines have been developed thus far. Standard treatments involve daily oral anti-retroviral therapy, which, despite its efficacy, can lead to notable long-term side effects. Recent clinical trial data have demonstrated encouraging therapeutic and preventive potential for bnAb therapies in both HIV-1-infected individuals and those without the infection. This review provides an overview of the advancements in HIV-1-specific bnAbs and discusses the insights gathered from recent clinical trials regarding their application in treating and preventing HIV-1 infection.

Schlagwörter

Stichwörter der Autor:innen

HIV1bnAbspreventiontreatmentviral reservoir

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, University of California CA, Irvine, Irvine, 92697 USA.

Zitieren

APA

Becerra, J. C., Hitchcock, L., Vu, K., & Gach, J. S. (2024). Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention. Microbial Cell, 11, 207-220. https://doi.org/10.15698/mic2024.07.826

Vancouver

Becerra JC, Hitchcock L, Vu K, Gach JS. Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention. Microbial Cell. 2024;11:207-220. doi:10.15698/mic2024.07.826

BibTeX
@article{Becerra2024,
  author = {Becerra, Juan C and Hitchcock, Lauren and Vu, Khoa and Gach, Johannes S},
  title = {Neutralizing the threat: harnessing broadly neutralizing antibodies against HIV-1 for treatment and prevention},
  journal = {Microbial Cell},
  year = {2024},
  volume = {11},
  pages = {207--220},
  doi = {10.15698/mic2024.07.826}
}
Kostenlos starten →